Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 3.29 billion Brazilian Reals [US$1.06 billion]
(2.10 billion Brazilian Reals [US$678.78 million]
of which 83%
was Diagnostic Medicine), and
Diagnosticos Da America SA
based in Brazil
(3.04 billion Brazilian Reals [US$984.69 million]
of which 100%
was servi os auxiliares).
During the year ended December of 2016, sales at
Genomma Lab Internacional Sab De Cv were 11.63 billion Mexican Pesos (US$611.08 million).
increase of 5.3%
versus 2015, when the company's sales were 11.04 billion Mexican Pesos.